Evidence map›Paper›PMID 35657957›Full record

ArticlePloS one2022

Health-related quality of life among cervical cancer survivors at a tertiary hospital in Ghana.

Kwabena Amo-Antwi, Ramatu Agambire, Thomas O Konney, Samuel B Nguah, Edward T Dassah, Yvonne Nartey, Adu Appiah-Kubi, Augustine Tawiah, Elliot K Tannor, Amponsah Peprah and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Risk Factors for Cervical Cancer in Ghana.Cancer reports (Hoboken, N.J.) · 2024
    Article
  10. An analysis of survivorship care strategies in national cancer control plans in Africa.Journal of cancer survivorship : research and practice · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Kwabena Amo-AntwiSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID 0000-0002-9412-0673
Ramatu AgambireDepartment of Nursing, Garden City University College, Kumasi, Ghana.
Thomas O KonneySchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Samuel B NguahSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Edward T DassahSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Yvonne NarteyDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
Adu Appiah-KubiSchool of Medical Sciences, University of Health and Allied Sciences, Ho, Ghana.
Augustine TawiahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Elliot K TannorSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Amponsah PeprahSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Mavis Bobie AnsahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Daniel SamKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Patrick K AkakpoSchool of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
Frank AnkobeaSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Rex M DjokotoSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Maame Y K IdunKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Henry S Opare-AddoSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Baafour K OpokuSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Alexander T OdoiSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Carolyn JohnstonUniversity of Michigan, Ann Arbor, Michigan, United States of America.
Kwame Nkrumah University of Science and Technology · GHKomfo Anokye Teaching Hospital · GHGarden City University College · GHUniversity of Cape Coast · GHUniversity of Health and Allied Sciences · GHUniversity of Michigan · USUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCervical cancer is the second most common female cancer in Ghana. The disease and its treatment significantly affect survivors' health-related quality of life (HRQoL). We determined the overall quality of life (QoL) and identified its predictors among cervical cancer survivors after treatment. MATERIALS AND

methodsA hospital-based cross-sectional analytical study was conducted on 153 disease-free cervical cancer survivors who completed curative treatment between January 2004 and December 2018 at Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. We used the European Organization for Research and Treatment of Cancer core-30 item (EORTC QLQ-C30) and cervical cancer module (EORTC QLQ-CX24) to assess the survivors' overall QoL. QoL domain scores were dichotomised as affected or unaffected by disease and its treatment. Significant differences between the affected and unaffected groups within each QoL domain were determined using the student T-test. We used Kruskal-Wallis and Dunn's tests to examine the difference in QoL domains between treatment types, with significance based on Bonferroni corrections. Multivariable logistic regression was performed to identify predictors of overall QoL. A p-value of less than 0.05 was considered statistically significant.

resultsOne hundred and fifty-three (153) women having a mean age of 58.3 (SD 11.4) years were studied. The overall QoL score was 79.6 (SD 16.0), and 74.5% of survivors reported good QoL score within the median follow up time of 41.8 months (interquartile range [IQR], 25.5-71.1 months) after cervical cancer diagnosis. Although the majority (66.0-84.3%) of the QoL functioning scale were unaffected, about a fifth (22.2%) to a third (34.5%) of the subjects had perceptual impairment in cognitive and role functioning. Financial difficulties, peripheral neuropathy and pain were most common symptoms reported as affected. A third of the survivors were worried that sex would be painful, and 36.6% indicated that their sexual activity as affected. The overall QoL scores for survivors who had surgery, chemoradiation and radiation-alone were 86.1 (SD 9.7), 76.9 (SD 17.7), and 80.7 (SD 14.7), respectively (p = 0.025). The predictors of survivor's overall QoL were loss of appetite [Adjusted Odd Ratio (AOR) = 9.34, 95% Confidence Interval (CI) = 2.13-35.8, p = 0.001], pain (AOR = 3.53, 95% CI = 1.25-9.31, p = 0.017) and body image (AOR = 5.89, 95% CI = 1.80-19.27, p = 0.003).

conclusionAbout 75% of the survivors had a good overall quality of life. Primary surgical treatment affords the best prospects for quality of life with the least symptom complaints and financial burden. Loss of appetite, pain or diminution in body image perception predicted the overall quality of life of cervical cancer survivors after treatment.

Indexed as

Cancer SurvivorsUterine Cervical NeoplasmsCross-Sectional StudiesFemaleGhanaHumansMiddle AgedPainQuality of LifeSurveys and QuestionnairesSurvivorsTertiary Care Centers

Identifiers

PMID35657957
PMCPMC9165899
OpenAlexW4281629424

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.